UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

November 2, 2010

Date of Report (Date of earliest event reported)

Actuate Corporation
(Exact name of registrant as specified in its charter)

Delaware 0-24607 94-3193197
(State of Incorporation) (Commission File Number) (IRS Employer

Identification Number)

2207 Bridgepointe Parkway
Suite 500
San Mateo, California 94404
(Address of principal executive offices)(Zip Code)
(650) 645-3000
(Registrant’s telephone number, including area code)
 
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02     Results of Operations and Financial Condition.

The information in this Report under Item 2.02, as well as Exhibit 99.1 attached hereto, is furnished pursuant to Item 2.02 of this Form 8-K. Consequently, it is not deemed “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. It may only be incorporated by reference in another filing under the Exchange Act or the Securities Act of 1933, as amended, if such subsequent filing specifically references this Form 8-K.

On November 2, 2010, Actuate Corporation issued a press release announcing its financial results for the third quarter of 2010. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 9.01     Financial Statements and Exhibits.

  (d) Exhibits.
 
Exhibit

No.

Description
 
 
99.1 Press release dated November 2, 2010.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

  Actuate Corporation
 
 
Date:

November 2, 2010

By: /s/ Peter I. Cittadini
Name: Peter I. Cittadini
Title: President and Chief Executive Officer

INDEX TO EXHIBITS

Exhibit No.   Description
 

99.1

Press release dated November 2, 2010.

Actuate Therapeutics (NASDAQ:ACTU)
Historical Stock Chart
Von Nov 2024 bis Dez 2024 Click Here for more Actuate Therapeutics Charts.
Actuate Therapeutics (NASDAQ:ACTU)
Historical Stock Chart
Von Dez 2023 bis Dez 2024 Click Here for more Actuate Therapeutics Charts.